Cargando…

Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat

BACKGROUND: Tamoxifen, a selective estrogen receptor modulator with both estrogenic and anti-estrogenic activity, is widely used as adjuvant therapy in breast cancer patients. Treatment with tamoxifen is associated with sexual side effects, such as increased vaginal dryness and pain/discomfort durin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Noel N, Stankovic, Miljan, Armagan, Abdullah, Cushman, Tulay T, Goldstein, Irwin, Traish, Abdulmaged M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590006/ https://www.ncbi.nlm.nih.gov/pubmed/16970814 http://dx.doi.org/10.1186/1472-6874-6-14

Ejemplares similares

Streptozotocin-induced diabetes in the rat is associated with changes in vaginal hemodynamics, morphology and biochemical markers
por: Kim, Noel N, et al.
Publicado: (2006)

Erratum: Correction of the references for Figures. Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2017)

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
por: Traish, Abdulmaged
Publicado: (2016)

Testosterone and weight loss: the evidence
por: Traish, Abdulmaged M.
Publicado: (2014)

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
por: Traish, Abdulmaged M.
Publicado: (2020)

Sex steroids and COVID-19 mortality in women
por: Traish, Abdulmaged M.
Publicado: (2021)

Androgens Modulate Endothelial Function and Endothelial Progenitor Cells in Erectile Physiology
por: Traish, Abdulmaged M., et al.
Publicado: (2013)

Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome
por: Traish, Abdulmaged M., et al.
Publicado: (2018)

Letter to the editor: Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer
por: Morgentaler, Abraham, et al.
Publicado: (2020)

Obesity and Erectile Dysfunction: Is Androgen Deficiency the Common Link?
por: Feeley, Robert J., et al.
Publicado: (2009)

The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
por: Traish, Abdulmaged M., et al.
Publicado: (2014)

SUN-222 Testosterone Treatment in Men with Classical vs. Functional Hypogonadism: A 9-Year Registry
por: Zitzmann, Michael, et al.
Publicado: (2019)

Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence
por: Traish, Abdulmaged, et al.
Publicado: (2018)

MON-091 Profound and Sustained Weight Loss in Men With Hypogonadism and Obesity Receiving Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

OR21-2 Lipid Profiles Improve in Men With Hypogonadism and Pre-existing Cardiovascular Disease Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): 10-year Data From a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

SUN-083 Hypertension and Hemodynamic Parameters in Men with Hypogonadism Improve Under Long-Term Treatment with Testosterone Undecanoate Injections (TU) Compared to Untreated Hypogonadal Control Patients
por: Saad, Farid, et al.
Publicado: (2019)

SUN-226 Improvements In Quality Of Life In Men With Hypogonadism Under Long-term Testosterone Therapy (TTh) With Testosterone Undecanoate Injections (TU): Experience From 6,500 Patient-years Ina Registry Study Ina Urological Setting
por: Haider, Karim, et al.
Publicado: (2019)

SUN-055 Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism Treated with Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU): 10-Year Data from a Registry Study in a Urological Setting
por: Saad, Farid, et al.
Publicado: (2019)

Analysis of the Ki-67 index in the vaginal epithelium of castrated rats treated with tamoxifen
por: Nery-Aguiar, Afif Rieth, et al.
Publicado: (2016)

Multidisciplinary Overview of Vaginal Atrophy and Associated Genitourinary Symptoms in Postmenopausal Women
por: Goldstein, Irwin, et al.
Publicado: (2013)

Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups
por: Traish, Abdulmaged M., et al.
Publicado: (2017)

International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
por: Parish, Sharon J., et al.
Publicado: (2021)

Immunodetection of nmt55/p54(nrb) isoforms in human breast cancer
por: Pavao, Matthew, et al.
Publicado: (2001)

Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years
por: Haider, Ahmad, et al.
Publicado: (2014)

Recognizing the True Value of Testosterone Therapy in Health Care
por: Morgentaler, Abraham, et al.
Publicado: (2022)

Remission of type 2 diabetes following long‐term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11‐year data from a real‐world registry study
por: Haider, Karim Sultan, et al.
Publicado: (2020)

Morphological and Immunohistochemical Study of Ovarian and Tubal Dysplasia Associated with Tamoxifen
por: Chene, G., et al.
Publicado: (2014)

Evaluation of the Effects of a New Intravaginal Gel, Containing Purified Bovine Colostrum, on Vaginal Blood Flow and Vaginal Atrophy in Ovariectomized Rat
por: Vailati, Silvia, et al.
Publicado: (2013)

Genital tuberculosis in a tamoxifen-treated postmenopausal woman with breast cancer and bloody vaginal discharge
por: Neonakis, Ioannis, et al.
Publicado: (2006)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Is Tamoxifen Use a Factor Affecting Continence in Breast Cancer Patients?
por: Imamoglu, Goksen Inanc, et al.
Publicado: (2019)

Sulfasalazine attenuates tamoxifen-induced toxicity in human retinal pigment epithelial cells
por: Hwang, Narae, et al.
Publicado: (2020)

IARC on tamoxifen.
Publicado: (1996)

Tamoxifen evolution
por: Howell, A., et al.
Publicado: (2023)

Impact of vaginal douching products on vaginal Lactobacillus, Escherichia coli and epithelial immune responses
por: Hesham, Helai, et al.
Publicado: (2021)

Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
por: Baildam, A. D., et al.
Publicado: (1987)

Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry
por: Bitton, Aric, et al.
Publicado: (2021)

Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling
por: Berard, Alicia R., et al.
Publicado: (2023)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hbjp93lotqbdgj6j8tdf2eh1q5